Victoria VanStekelenburg represents private equity firms and their portfolio companies in mergers, acquisitions, and other complex business transactions.
Drawing on her experience in multifaceted and cross-border private equity matters, Victoria helps clients successfully and expeditiously navigate significant deals. She regularly advises on multijurisdictional transactions involving companies that operate worldwide. Her deal work encompasses diverse industries, from technology and manufacturing to government contracts and consumer products.
Victoria counsels clients throughout every stage of the investment lifecycle, from purchase to sale. She also works with portfolio companies over the course of their life with a fund, including in connection with add-on acquisitions and governance matters. Regardless of the matter at hand, Victoria applies big-picture thinking and a collaborative approach to help clients address key legal and business challenges.
Victoria has held several firm leadership roles and is currently on the firm's Recruiting Committee. She previously served as Co-Chair of the firm’s D.C. Women Lawyers Group, an affinity group that fosters connections among women lawyers. She also previously served on the firm’s Associates Committee, a body comprising associates and partners that manages associate performance reviews and makes partnership recommendations, as well as the Training & Career Enhancement Committee, which develops and oversees in-house training and mentoring programs for associates.
Experience
Victoria's experience includes advising:
The Carlyle Group in its:
€10.1 billion leveraged acquisition of AkzoNobel’s specialty chemicals business
Take-private acquisition with GTCR of Albany Molecular Research
US$2.07 billion sale of Landmark Aviation, an operator of a global network of fixed-base operations (FBOs), aircraft maintenance and aircraft management, and charter businesses, to BBA Aviation
Approximately US$122 million sale of Primatics Financial, an enterprise software company, to SS&C Technologies
US$4.15 billion acquisition of Ortho-Clinical Diagnostics, a global provider of solutions for screening and confirming diseases, from Johnson & Johnson
US$1.45 billion sale of Precision Flow Systems by BC Partners and Carlyle to Ingersoll-Rand plc (NYSE: IR)
US$1.9 billion sale of Wesco Aircraft, a provider of supply chain management services to the global aerospace industry, to Platinum Equity
Acquisition of Unison Software, a provider of software for federal agencies and government contractors
Platinum Equity in its:
€200 million divestiture of the European and Asian operations of Mactac, a global pressure-sensitive materials business, to Avery Dennison
Joint venture with Ball and the acquisition of Ball’s tinplate food and aerosol packaging businesses
US$3.85 billion acquisition of Husky Injection Molding Systems, a leading supplier of injection molding equipment and services to the global plastics industry
DC Capital Partners in connection with:
An affiliate’s strategic investment in Revenue Solutions, a provider of public sector tax processing and compliance software
A strategic partnership between DC Capital Partners and Digital Force Technologies, a manufacturer of force protection and tactical surveillance products for government customers
Pharmaceutical Product Development, a leading global contract research organization, in its acquisition from Symphony Technology Group of Evidera
Capitol Acquisition Corporation III in its combination with Cision at an enterprise value of approximately US$2.4 billion
An investment fund and asset management business specializing in the acquisition of cash flows arising from intellectual property in film, television, and music, in the sale of its asset management business to a blue-chip private equity firm
Qualifications
Bar Qualification
District of Columbia
New York
Education
JD, Georgetown Law School magna cum laude, Order of the Coif
Firm honored by Law360 for advising startups, financial institutions, VCs, digital asset and Web3 participants, and corporations on their most innovative and complex transactions, investigations, litigation, and regulatory matters.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.